Escend Press Release Saira Bates 6/20/24 Escend Press Release Saira Bates 6/20/24 Escend Announces Poster Presentation at the Annual Meeting of the European Hematology Association from an Investigator-Initiated Phase I/II study evaluating ES-3000 in Myelodysplastic Syndrome (MDS) Read More Escend Press Release PJ Welsch 7/15/22 Escend Press Release PJ Welsch 7/15/22 Escend Pharmaceuticals, Inc., Receives IND Clearance from the FDA for ES-3000 Phase I Study in Relapsed or Refractory Acute Myeloid Leukemia (AML) Read More
Escend Press Release Saira Bates 6/20/24 Escend Press Release Saira Bates 6/20/24 Escend Announces Poster Presentation at the Annual Meeting of the European Hematology Association from an Investigator-Initiated Phase I/II study evaluating ES-3000 in Myelodysplastic Syndrome (MDS) Read More
Escend Press Release PJ Welsch 7/15/22 Escend Press Release PJ Welsch 7/15/22 Escend Pharmaceuticals, Inc., Receives IND Clearance from the FDA for ES-3000 Phase I Study in Relapsed or Refractory Acute Myeloid Leukemia (AML) Read More
